Chairman and CEO Kevin Hrusovsky to present at BIO and provide details about the HD-X launch and vision for continuing to pioneer disruption in healthcare with digital biomarkers Billerica, Mass. – Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, announced that it issued approximately 2.2 million […]
Cambridge: Qkine, specialist manufacturer of proteins for stem cell, organoid and regenerative medicine applications has closed a further round of investment. The £550k funding round was led by Cambridge Enterprise and five angel investors – all of whom followed initial seed investments made in April 2018. Joining the original investors is biotech entrepreneur and founder member of […]
Partnership with US Department of Energy and Agile BioFoundry to accelerate microbial engineering for cost-competitive production of new biochemicals BERKELEY, Calif. — Lygos, Inc., a full-stack producer of specialty chemicals that deliver high-value performance without the environmental toxicity, today announced that it was awarded a $2 million grant by the United States Department of Energy (DOE). The grant […]
OAKLAND, Calif. — Riffyn, a global provider of Software-as-a-Service (SaaS) for scientific process design and data analytics, announces the close of a $15 million Series B financing led by M Ventures with participation from Waters Corporation, O’Reilly AlphaTech Ventures, and Plug and Play Ventures. Funds will be used to globally expand sales and scientific services, […]
RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries, announced today the closing of its initial public offering of 238,050,000 shares of its common stock at a price to the public of $14.00per share, […]
BEVERLY, Mass. — Sage Science, a developer of products for improving sample preparation processes in life science applications, today announced the award of $1.8M from the National Human Genome Research Institute. The grant funds a two-year program to develop and commercialize a fully automated platform for its HLS-CATCH targeted DNA sample preparation process. The HLS-CATCH […]
New funding to support platform advancements and proprietary pipeline expansion NEW YORK – Schrödinger today announced that several new investors have joined its latest funding round, which was completed with a total raise of $110 million to support continued advancement of the company’s industry-leading computational platform and expansion of its therapeutic pipeline. New investors include […]
– Avantor enterprise value grows from $280 million in 2010 to over $14 billion today, under New Mountain’s ownership – Avantor has emerged as a global leader in life sciences materials NEW YORK–New Mountain Capital, LLC, (“New Mountain”), a growth-oriented private equity firm with over $20 billion in assets under management, today announced the initial […]
Oversubscribed round led by LSP will fund accelerated product development and commercial operations in the U.S. PARIS – DNA Script today announced an oversubscribed Series B fundraising of $38.5M led by LSP, one of Europe’s largest and most experienced healthcare investment firms. Bpifrance, through its Large Venture fund, joined the round, alongside existing investors Illumina Ventures, […]
BRANFORD, Conn. — IsoPlexis, a company focused on advancing single-cell biomarkers to address critical challenges in oncology & beyond, today announced that it had raised $25 million in Series C funding. The round was led by Northpond Ventures and included new strategic investment along with current investors Spring Mountain Capital, Ironwood Capital, North Sound Capital, and Connecticut Innovations. In […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
